Tyra Biosciences: Pro-forma Cash Position of About $403.5 M Expected to Support Clinical and Operational Milestones Through at Least 2026 >TYRA
Tyra Biosciences: Pro-forma Cash Position of About $403.5 M Expected to Support Clinical and Operational Milestones Through at Least 2026 >TYRA
Tyra Biosciences：預計約4.035億美元的預計現金狀況將在至少2026年之前支持臨床和運營里程碑 >TYRA
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊